Washburn Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-828
Closed -$447K 37
2024
Q1
$447K Sell
828
-175
-17% -$95.6K 0.33% 32
2023
Q4
$557K Sell
1,003
-584
-37% -$274K 0.42% 30
2023
Q3
$694K Buy
1,587
+60
+4% +$29.9K 0.59% 27
2023
Q2
$767K Buy
1,527
+235
+18% +$113K 0.64% 25
2023
Q1
$646K Sell
1,292
-145
-10% -$69.4K 0.56% 30
2022
Q4
$586K Buy
1,437
+100
+7% +$38.8K 0.53% 31
2022
Q3
$436K Buy
1,337
+75
+6% +$27.6K 0.42% 34
2022
Q2
$443K Sell
1,262
-65
-5% -$26.5K 0.38% 39
2022
Q1
$726K Sell
1,327
-195
-13% -$103K 0.48% 32
2021
Q4
$1M Sell
1,522
-5
-0.3% -$3.14K 0.6% 27
2021
Q3
$950K Buy
1,527
+10
+0.7% +$6.72K 0.62% 28
2021
Q2
$958K Hold
1,517
0.64% 26
2021
Q1
$742K Sell
1,517
-78
-5% -$39.1K 0.5% 36
2020
Q4
$797K Hold
1,595
0.55% 33
2020
Q3
$627K Sell
1,595
-30
-2% -$11.1K 0.5% 33
2020
Q2
$537K Buy
1,625
+10
+0.6% +$2.9K 0.49% 34
2020
Q1
$391K Sell
1,615
-50
-3% -$13K 0.54% 25
2019
Q4
$435K Buy
+1,665
New +$439K 0.39% 28

Other funds holding IDXX

Washburn Capital Management's IDXX Position: Q2 2024 in Review

Washburn Capital Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 828 shares — an estimated $447K sold.

Washburn Capital Management first reported a position in IDXX in Q4 2019 and held it in 18 quarters. The position peaked at $1M in Q4 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Washburn Capital Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
  • Washburn Capital Management sold 828 Idexx Laboratories shares in Q2 2024, an estimated $447K.
  • Washburn Capital Management first reported a position in Idexx Laboratories in Q4 2019 and held it in 18 quarters.
  • Washburn Capital Management's Idexx Laboratories position peaked at $1M in Q4 2021.
  • 1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Washburn Capital Management's 13F filing for Q2 2024, filed 25 Jul 2024.